TFIPS
ABBV icon

Towarzystwo Funduszy Inwestycyjnych PZU SA’s AbbVie ABBV Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
8,698
+39
+0.5% +$8.39K 0.62% 24
2026
Q1 		$1.88M Buy
8,659
+842
+11% +$187K 0.63% 25
2025
Q4 		$1.79M Buy
7,817
+5
+0.1% +$1.14K 0.45% 33
2025
Q3 		$1.81M Sell
7,812
-5,490
-41% -$1.12M 0.43% 32
2025
Q2 		$2.47M Sell
13,302
-236
-2% -$43.9K 0.69% 27
2025
Q1 		$2.84M Sell
13,538
-2,232
-14% -$434K 0.97% 19
2024
Q4 		$2.8M Sell
15,770
-435
-3% -$80K 0.92% 19
2024
Q3 		$3.2M Buy
16,205
+1,260
+8% +$235K 1.16% 15
2024
Q2 		$2.56M Buy
14,945
+95
+0.6% +$15.7K 0.96% 18
2024
Q1 		$2.7M Buy
14,850
+385
+3% +$66.4K 1.15% 15
2023
Q4 		$2.24M Buy
+14,465
New +$2.11M 1.03% 16
2021
Q3 		$1.23M Buy
11,391
+900
+9% +$103K 1.47% 12
2021
Q2 		$1.18M Buy
10,491
+205
+2% +$23.1K 1.4% 10
2021
Q1 		$1.11M Sell
10,286
-1,580
-13% -$169K 1.62% 8
2020
Q4 		$1.27M Buy
+11,866
New +$1.14M 1.32% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's ABBV Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its AbbVie (ABBV) stake by 0.45% in Q2 2026, buying an estimated $8.39K and bringing the position to 8,698 shares worth $2.19M. The position accounts for 0.62% of the portfolio, ranked #24.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in ABBV in Q4 2020 and has held it in 15 quarters since. The position peaked at $3.2M in Q3 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 8,698 shares of AbbVie worth $2.19M as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA bought 39 AbbVie shares in Q2 2026, an estimated $8.39K.
  • AbbVie made up 0.62% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #24 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in AbbVie in Q4 2020 and has held it in 15 quarters since.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's AbbVie position peaked at $3.2M in Q3 2024.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.